Which has stronger earnings and valuation, OSCR or PINC?

Premier has lower revenue, but higher earnings than Oscar Health. Premier is trading at a lower price-to-earnings ratio than Oscar Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Oscar Health $11.70B 0.85 -$443.15M $1.40 23.00 Premier $1.00B 4.09 $20.27M -$0.27 N/A

Is OSCR or PINC more profitable?

Oscar Health has a net margin of 3.60% compared to Premier's net margin of -3.28%. Oscar Health's return on equity of 38.45% beat Premier's return on equity. Company Net Margins Return on Equity Return on Assets Oscar Health 3.60% 38.45% 6.76% Premier -3.28% 6.84% 3.48%

Which has better earnings and valuation, HQY or PINC?

HealthEquity has higher revenue and earnings than Premier. Premier is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio HealthEquity $1.31B 6.05 $215.20M $2.77 34.68 Premier $1.00B 4.09 $20.27M -$0.27 N/A

Is HQY or PINC more profitable?

HealthEquity has a net margin of 17.36% compared to Premier's net margin of -3.28%. HealthEquity's return on equity of 15.33% beat Premier's return on equity. Company Net Margins Return on Equity Return on Assets HealthEquity 17.36% 15.33% 9.51% Premier -3.28% 6.84% 3.48%

Which has higher earnings & valuation, HNGE or PINC?

Premier has higher revenue and earnings than Hinge Health. Premier is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hinge Health $587.86M 12.66 -$528.26M $1.28 72.03 Premier $1.00B 4.09 $20.27M -$0.27 N/A

Is HNGE or PINC more profitable?

Hinge Health has a net margin of 15.15% compared to Premier's net margin of -3.28%. Hinge Health's return on equity of 51.60% beat Premier's return on equity. Company Net Margins Return on Equity Return on Assets Hinge Health 15.15% 51.60% 14.16% Premier -3.28% 6.84% 3.48%

Which has preferable valuation & earnings, CHE or PINC?

Chemed has higher revenue and earnings than Premier. Premier is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Chemed $2.60B 2.62 $265.24M $19.91 26.16 Premier $1.00B 4.09 $20.27M -$0.27 N/A

Is CHE or PINC more profitable?

Chemed has a net margin of 10.60% compared to Premier's net margin of -3.28%. Chemed's return on equity of 31.77% beat Premier's return on equity. Company Net Margins Return on Equity Return on Assets Chemed 10.60% 31.77% 18.90% Premier -3.28% 6.84% 3.48%

This company has been marked as potentially delisted and may not be actively trading.

Premier (PINC) Competitors

Compare

PINC vs. OSCR, HQY, HNGE, CHE, and HIMS

Should you buy Premier stock or one of its competitors? Premier's main competitors and comparable companies include Oscar Health (OSCR), HealthEquity (HQY), Hinge Health (HNGE), Chemed (CHE), and Hims & Hers Health (HIMS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare providers & services" industry.

How does Premier compare to Oscar Health?

Oscar Health (NYSE:OSCR) and Premier (NASDAQ:PINC) are both mid-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, dividends, risk, media sentiment and earnings.

Oscar Health has a beta of 2.37, suggesting that its stock price is 137% more volatile than the broader market. Comparatively, Premier has a beta of 0.64, suggesting that its stock price is 36% less volatile than the broader market.

Oscar Health has a net margin of 3.60% compared to Premier's net margin of -3.28%. Oscar Health's return on equity of 38.45% beat Premier's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Oscar Health	3.60%	38.45%	6.76%
Premier	-3.28%	6.84%	3.48%

Oscar Health presently has a consensus target price of $26.22, suggesting a potential downside of 18.56%. Premier has a consensus target price of $28.25, suggesting a potential downside of 43.25%. Given Oscar Health's stronger consensus rating and higher possible upside, equities analysts plainly believe Oscar Health is more favorable than Premier.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oscar Health	0 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.42
Premier	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Premier has lower revenue, but higher earnings than Oscar Health. Premier is trading at a lower price-to-earnings ratio than Oscar Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oscar Health	$11.70B	0.85	-$443.15M	$1.40	23.00
Premier	$1.00B	4.09	$20.27M	-$0.27	N/A

75.7% of Oscar Health shares are held by institutional investors. Comparatively, 74.4% of Premier shares are held by institutional investors. 22.6% of Oscar Health shares are held by insiders. Comparatively, 1.0% of Premier shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Oscar Health had 9 more articles in the media than Premier. MarketBeat recorded 9 mentions for Oscar Health and 0 mentions for Premier. Oscar Health's average media sentiment score of 0.73 beat Premier's score of 0.00 indicating that Oscar Health is being referred to more favorably in the media.

Company	Overall Sentiment
Oscar Health	Positive
Premier	Neutral

Summary

Oscar Health beats Premier on 15 of the 17 factors compared between the two stocks.

How does Premier compare to HealthEquity?

HealthEquity (NASDAQ:HQY) and Premier (NASDAQ:PINC) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends.

HealthEquity presently has a consensus price target of $111.87, indicating a potential upside of 16.44%. Premier has a consensus price target of $28.25, indicating a potential downside of 43.25%. Given HealthEquity's stronger consensus rating and higher possible upside, equities research analysts plainly believe HealthEquity is more favorable than Premier.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.85
Premier	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

HealthEquity has a net margin of 17.36% compared to Premier's net margin of -3.28%. HealthEquity's return on equity of 15.33% beat Premier's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.36%	15.33%	9.51%
Premier	-3.28%	6.84%	3.48%

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 74.4% of Premier shares are owned by institutional investors. 1.6% of HealthEquity shares are owned by insiders. Comparatively, 1.0% of Premier shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

HealthEquity has a beta of 0.22, suggesting that its share price is 78% less volatile than the broader market. Comparatively, Premier has a beta of 0.64, suggesting that its share price is 36% less volatile than the broader market.

HealthEquity has higher revenue and earnings than Premier. Premier is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.31B	6.05	$215.20M	$2.77	34.68
Premier	$1.00B	4.09	$20.27M	-$0.27	N/A

In the previous week, HealthEquity had 10 more articles in the media than Premier. MarketBeat recorded 10 mentions for HealthEquity and 0 mentions for Premier. HealthEquity's average media sentiment score of 0.99 beat Premier's score of 0.00 indicating that HealthEquity is being referred to more favorably in the media.

Company	Overall Sentiment
HealthEquity	Positive
Premier	Neutral

Summary

HealthEquity beats Premier on 16 of the 17 factors compared between the two stocks.

How does Premier compare to Hinge Health?

Hinge Health (NYSE:HNGE) and Premier (NASDAQ:PINC) are both mid-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, media sentiment, valuation, earnings, institutional ownership, analyst recommendations and dividends.

Hinge Health has a net margin of 15.15% compared to Premier's net margin of -3.28%. Hinge Health's return on equity of 51.60% beat Premier's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hinge Health	15.15%	51.60%	14.16%
Premier	-3.28%	6.84%	3.48%

Hinge Health currently has a consensus price target of $100.57, indicating a potential upside of 9.08%. Premier has a consensus price target of $28.25, indicating a potential downside of 43.25%. Given Hinge Health's stronger consensus rating and higher possible upside, equities research analysts plainly believe Hinge Health is more favorable than Premier.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hinge Health	1 Sell rating(s)	2 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.83
Premier	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

74.4% of Premier shares are held by institutional investors. 18.9% of Hinge Health shares are held by insiders. Comparatively, 1.0% of Premier shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Premier has higher revenue and earnings than Hinge Health. Premier is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hinge Health	$587.86M	12.66	-$528.26M	$1.28	72.03
Premier	$1.00B	4.09	$20.27M	-$0.27	N/A

In the previous week, Hinge Health had 2 more articles in the media than Premier. MarketBeat recorded 2 mentions for Hinge Health and 0 mentions for Premier. Hinge Health's average media sentiment score of 1.11 beat Premier's score of 0.00 indicating that Hinge Health is being referred to more favorably in the media.

Company	Overall Sentiment
Hinge Health	Positive
Premier	Neutral

Hinge Health has a beta of 1.38, meaning that its stock price is 38% more volatile than the broader market. Comparatively, Premier has a beta of 0.64, meaning that its stock price is 36% less volatile than the broader market.

Summary

Hinge Health beats Premier on 14 of the 17 factors compared between the two stocks.

How does Premier compare to Chemed?

Chemed (NYSE:CHE) and Premier (NASDAQ:PINC) are both mid-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, dividends, earnings, institutional ownership, analyst recommendations, valuation and media sentiment.

Chemed has a beta of 0.51, meaning that its share price is 49% less volatile than the broader market. Comparatively, Premier has a beta of 0.64, meaning that its share price is 36% less volatile than the broader market.

Chemed has a net margin of 10.60% compared to Premier's net margin of -3.28%. Chemed's return on equity of 31.77% beat Premier's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemed	10.60%	31.77%	18.90%
Premier	-3.28%	6.84%	3.48%

Chemed has higher revenue and earnings than Premier. Premier is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemed	$2.60B	2.62	$265.24M	$19.91	26.16
Premier	$1.00B	4.09	$20.27M	-$0.27	N/A

In the previous week, Chemed had 10 more articles in the media than Premier. MarketBeat recorded 10 mentions for Chemed and 0 mentions for Premier. Chemed's average media sentiment score of 1.45 beat Premier's score of 0.00 indicating that Chemed is being referred to more favorably in the media.

Company	Overall Sentiment
Chemed	Positive
Premier	Neutral

95.8% of Chemed shares are owned by institutional investors. Comparatively, 74.4% of Premier shares are owned by institutional investors. 3.3% of Chemed shares are owned by insiders. Comparatively, 1.0% of Premier shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Chemed pays an annual dividend of $2.80 per share and has a dividend yield of 0.5%. Premier pays an annual dividend of $0.84 per share and has a dividend yield of 1.7%. Chemed pays out 14.1% of its earnings in the form of a dividend. Premier pays out -311.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Chemed has raised its dividend for 16 consecutive years. Premier is clearly the better dividend stock, given its higher yield and lower payout ratio.

Chemed presently has a consensus target price of $530.75, indicating a potential upside of 1.91%. Premier has a consensus target price of $28.25, indicating a potential downside of 43.25%. Given Chemed's stronger consensus rating and higher probable upside, research analysts clearly believe Chemed is more favorable than Premier.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemed	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17
Premier	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Chemed beats Premier on 15 of the 19 factors compared between the two stocks.

How does Premier compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Premier (NASDAQ:PINC) are both mid-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation and institutional ownership.

Hims & Hers Health has a beta of 2.42, indicating that its stock price is 142% more volatile than the broader market. Comparatively, Premier has a beta of 0.64, indicating that its stock price is 36% less volatile than the broader market.

Premier has a net margin of -3.28% compared to Hims & Hers Health's net margin of -5.51%. Premier's return on equity of 6.84% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-5.51%	-6.51%	-1.20%
Premier	-3.28%	6.84%	3.48%

Hims & Hers Health presently has a consensus price target of $32.50, indicating a potential upside of 17.50%. Premier has a consensus price target of $28.25, indicating a potential downside of 43.25%. Given Hims & Hers Health's stronger consensus rating and higher possible upside, research analysts clearly believe Hims & Hers Health is more favorable than Premier.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19
Premier	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Hims & Hers Health has higher revenue and earnings than Premier. Premier is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	2.75	$128.37M	-$0.63	N/A
Premier	$1.00B	4.09	$20.27M	-$0.27	N/A

In the previous week, Hims & Hers Health had 52 more articles in the media than Premier. MarketBeat recorded 52 mentions for Hims & Hers Health and 0 mentions for Premier. Hims & Hers Health's average media sentiment score of 0.17 beat Premier's score of 0.00 indicating that Hims & Hers Health is being referred to more favorably in the media.

Company	Overall Sentiment
Hims & Hers Health	Neutral
Premier	Neutral

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 74.4% of Premier shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by insiders. Comparatively, 1.0% of Premier shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Hims & Hers Health beats Premier on 10 of the 16 factors compared between the two stocks.

Get Premier News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PINC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PINC vs. The Competition

Export

Metric	Premier	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.33B	$10.00B	$7.24B	$12.91B
Dividend Yield	2.97%	2.59%	2.53%	9.14%
P/E Ratio	-184.37	34.60	274.10	25.45
Price / Sales	4.09	5.71	687.92	125.90
Price / Cash	9.74	121.42	77.08	52.44
Price / Book	2.69	3.99	12.85	6.17
Net Income	$20.27M	$313.25M	$3.49B	$350.08M

Premier Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PINC Premier	N/A	$49.78 +76.7%	$28.25 -43.3%	+92.6%	$2.33B	$1.00B	N/A	2,700
OSCR Oscar Health	4.2108 of 5 stars	$29.39 -1.9%	$26.22 -10.8%	+65.9%	$9.07B	$11.70B	20.98	2,305
HQY HealthEquity	4.3759 of 5 stars	$97.90 +1.4%	$111.87 +14.3%	+5.0%	$8.10B	$1.31B	35.34	2,814	Positive News Analyst Forecast
HNGE Hinge Health	3.395 of 5 stars	$90.71 -2.0%	$100.57 +10.9%	+67.9%	$7.29B	$587.86M	70.62	1,437	Positive News
CHE Chemed	3.6485 of 5 stars	$516.68 -0.4%	$530.75 +2.7%	+11.8%	$6.75B	$2.53B	25.96	15,811	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PINC) was last updated on 9/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Premier (PINC) Competitors

PINC vs. OSCR, HQY, HNGE, CHE, and HIMS

How does Premier compare to Oscar Health?

Summary

How does Premier compare to HealthEquity?

Summary

How does Premier compare to Hinge Health?

Summary

How does Premier compare to Chemed?

Summary

How does Premier compare to Hims & Hers Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PINC vs. The Competition

Premier Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Premier (PINC) Competitors

PINC vs. OSCR, HQY, HNGE, CHE, and HIMS

How does Premier compare to Oscar Health?

Which has more risk and volatility, OSCR or PINC?

Is OSCR or PINC more profitable?

Do analysts rate OSCR or PINC?

Which has stronger earnings and valuation, OSCR or PINC?

Do institutionals and insiders hold more shares of OSCR or PINC?

Does the media refer more to OSCR or PINC?

Summary

How does Premier compare to HealthEquity?

Do analysts recommend HQY or PINC?

Is HQY or PINC more profitable?

Do insiders & institutionals believe in HQY or PINC?

Which has more risk & volatility, HQY or PINC?

Which has better earnings and valuation, HQY or PINC?

Does the media refer more to HQY or PINC?

Summary

How does Premier compare to Hinge Health?

Is HNGE or PINC more profitable?

Do analysts prefer HNGE or PINC?

Do institutionals and insiders believe in HNGE or PINC?

Which has higher earnings & valuation, HNGE or PINC?

Does the media refer more to HNGE or PINC?

Which has more risk & volatility, HNGE or PINC?

Summary

How does Premier compare to Chemed?

Which has more volatility and risk, CHE or PINC?

Is CHE or PINC more profitable?

Which has preferable valuation & earnings, CHE or PINC?

Does the media refer more to CHE or PINC?

Do insiders and institutionals have more ownership in CHE or PINC?

Is CHE or PINC a better dividend stock?

Do analysts rate CHE or PINC?

Summary

How does Premier compare to Hims & Hers Health?

Which has more volatility & risk, HIMS or PINC?

Is HIMS or PINC more profitable?

Do analysts recommend HIMS or PINC?

Which has preferable earnings & valuation, HIMS or PINC?

Does the media refer more to HIMS or PINC?

Do institutionals and insiders believe in HIMS or PINC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PINC vs. The Competition

Premier Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools